Staging Paradox and recurrence pattern among stage IIB, IIC, and IIIA Colon cancers: a retrospective cohort study
International Journal of Colorectal Disease · 2024
DOI: 10.1007/s00384-024-04737-1 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Colorectal Disease, 2024. Verfasst von Yu-Tso Liao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Colonic Neoplasms, Neoplasm Staging, Neoplasm Recurrence, Local. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University Hospital Hsin-Chu Branch.
Abstract (Originalsprache)
Purpose
The survival rates of patients with stage IIB and IIC colon cancer are paradoxically inferior to that of patients with stage IIIA colon cancer. This study aimed to examine the oncological outcomes and investigate the factors that could affect the staging paradox among stage IIB, IIC, and IIIA colon cancers based on a 9-year cancer database.
Methods
Patients with stage IIB (pT4aN0M0), IIC (pT4bN0M0), or IIIA (pT1-2N1M0) colon cancer were retrospectively selected from a prospectively maintained medical database from January 2011 to December 2019. Factors that might influence the staging paradox, including radicality, harvested lymph nodes, and chemotherapy administration, were examined.
Results
A total of 282 patients (stage IIB, n = 59; stage IIC, n = 46; and stage IIIA, n = 177) were enrolled. Patients with stage IIB/C cancer demonstrated higher carcinoembryonic antigen levels, larger tumor size, more frequent tumor obstruction, and higher locoregional recurrence than those with stage IIIA cancer. With respect to 10-year locoregional recurrence-free survival and cancer-specific survival, patients with stage IIB and IIC cancers had significantly lower survival rates than did those with stage IIIA cancer (73.7% vs. 66.3% vs. 91.2%, P = 0.0003; 5.4% vs. 10.9% vs. 11.2%, P = 0.0023). The staging paradox persisted in patients who underwent R0 resection, had harvested lymph nodes ≥ 12, and received chemotherapy, as confirmed by multivariate regression analysis.
Conclusions
Based on the inferior oncological outcomes and higher locoregional recurrence rate, this study highlighted the need for intensified cytotoxic chemotherapy specific to this recurrence pattern for patients with stage IIB/C colon cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Division of Colorectal Surgery, Department of Surgery, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan.
- Division of Colorectal Surgery, Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
- Division of Colorectal Surgery, Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan. jintung@ntu.edu.tw.
Förderung
- National Taiwan University Hospital Hsin-Chu Branch
Zitieren
APA
Liao, Y. T., Huang, J., Hung, J. S., Huang, K. W., & Liang, J. T. (2024). Staging Paradox and recurrence pattern among stage IIB, IIC, and IIIA Colon cancers: a retrospective cohort study. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04737-1
Vancouver
Liao YT, Huang J, Hung JS, Huang KW, Liang JT. Staging Paradox and recurrence pattern among stage IIB, IIC, and IIIA Colon cancers: a retrospective cohort study. International Journal of Colorectal Disease. 2024. doi:10.1007/s00384-024-04737-1
BibTeX
@article{Liao2024,
author = {Liao, Yu-Tso and Huang, John and Hung, Ji-Shiang and Huang, Kai-Wen and Liang, Jin-Tung},
title = {Staging Paradox and recurrence pattern among stage IIB, IIC, and IIIA Colon cancers: a retrospective cohort study},
journal = {International Journal of Colorectal Disease},
year = {2024},
doi = {10.1007/s00384-024-04737-1}
}
EUVIMED